Diverse AI with Rajvir Madan
The diverse applications of artificial intelligence are transforming industries at an unprecedented pace, but with great breakthroughs come complex challenges.
Today I’m joined by Rajvir Madan, Chief Digital and Technology Officer at Arcutis Biotherapeutics, to break down the transformative impact AI is having in our field.
Our discussion spans from the reduction of drug discovery timelines to addressing ethical concerns related to data biases. We also confront challenges tied to data quality and the implications for the workforce in the era of AI.
To grasp the full spectrum of AI’s influence on biotech and the vision it’s charting for our future, tune in for a compelling episode.
Specifically, this episode highlights the following themes:
- Dissecting AI’s impact on biotech
- AI benefits, cautious of challenges and ethics
- Addressing challenges in digital transformation for businesses
Links from this episode:
- Get to know more about Steven Swan: https://www.linkedin.com/in/swangroup
- Get to know more about Rajvir Madan: https://www.linkedin.com/in/rajvir-raj-madan-3a74252
==== Time Stamps ====
00:00 – Introduction
00:40 – About Rajvir Madan
05:41 – Ensure accurate, reliable data for model refinement
07:48 – Companies leveraging genetic data to improve AI models
09:53 – Underutilized medical data sets need proper mining
13:01 – Engineer emphasizes a problem-focused approach to AI
19:10 – Generative AI hype may not be necessary
20:34 – Simplified definition of generative AI and models
24:21 – Technology trends: AI, AR, VR, metaverse, quantum computing
28:07 – Growing up Indian, learning self-advocacy, promoting diversity
32:54 – Caution is needed with the rapid growth of technology
